celiacFacts: Alvine Pharmaceuticals Announces Positive Results From Phase 2a Trial of ALV003 in Celiac Disease Patients. Clinical Proof-of-Principle Achieved, Company to Begin Phase 2b Trial in 2012.

Monday, October 24, 2011

Alvine Pharmaceuticals Announces Positive Results From Phase 2a Trial of ALV003 in Celiac Disease Patients. Clinical Proof-of-Principle Achieved, Company to Begin Phase 2b Trial in 2012.

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)